Myeloid Neoplasm
📧 Sign up to get email alerts when something new happens for Myeloid Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease [Phase 2]
Phase 2 trial comparing CPX-351 to immediate stem cell transplantation for high-grade myeloid cancers with measurable residual disease was t…
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm [Phase 2]
Phase 2 trial evaluating higher or lower doses of cladribine, cytarabine, and mitoxantrone in medically less fit patients with newly diagnos…
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms [Phase 2]
Phase 2 trial evaluating early allogeneic hematopoietic cell transplantation for patients with relapsed or refractory high-grade myeloid neo…
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 3]
Phase 3 study evaluating the combination of bortezomib and sorafenib tosylate in newly diagnosed acute myeloid leukemia has posted results. …
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 3]
Phase 3 trial evaluating bortezomib with sorafenib tosylate in newly diagnosed acute myeloid leukemia has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant [Phase 3]
Phase 3 trial updating chlorhexidine gluconate cleansing for preventing central line-associated bloodstream infections and MDR organism acqu…